Lower Gwynedd, PA, United States of America

Douglas C Beshore

USPTO Granted Patents = 34 

 

 

Average Co-Inventor Count = 3.8

ph-index = 5

Forward Citations = 76(Granted Patents)


Location History:

  • Lansdale, PA (US) (2002)
  • Harleysville, PA (US) (2010 - 2011)
  • North Wales, PA (US) (2011)
  • Gwynedd, PA (US) (2014 - 2016)
  • Philadelphia, PA (US) (2016)
  • West Point, PA (US) (2015 - 2017)
  • Lower Gywnedd, PA (US) (2017)
  • Lower Gwynedd, PA (US) (2009 - 2020)

Company Filing History:


Years Active: 2002-2025

Loading Chart...
Loading Chart...
Loading Chart...
34 patents (USPTO):

Title: Innovations and Contributions of Douglas C. Beshore

Introduction: Douglas C. Beshore, a notable inventor based in Lower Gwynedd, PA, has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds targeting orexin receptors. With a remarkable total of 33 patents to his name, Beshore's work has the potential to address critical neurological and psychiatric disorders.

Latest Patents: Among his latest inventions, Beshore has developed "Fused Heteroaryl Derivatives as Orexin Receptor Antagonists." This invention focuses on fused heteroaryl derivative compounds, which serve as antagonists to orexin receptors. The applications of these compounds in treating or preventing various neurological and psychiatric disorders underscore their importance. Additionally, he has produced the patent for "Piperidine Isoxazole and Isothiazole Orexin Receptor Antagonists," which pertains to piperidine isoxazole and isothiazole compounds designed to inhibit orexin receptors. Similar to his previous work, this invention highlights therapeutic uses in preventing or treating disorders linked to orexin receptors, along with associated pharmaceutical compositions.

Career Highlights: Throughout his career, Beshore has collaborated with some of the most reputable companies in the pharmaceutical industry, notably Merck Sharp & Dohme Corporation and Merck & Company, Inc. His work in these organizations has allowed him to advance medical research and contribute to innovative pharmacological solutions.

Collaborations: Beshore has worked alongside talented colleagues in the field, including Scott D. Kuduk and Christopher J. Dinsmore. Their collaborative efforts have likely enhanced the quality and impact of the patents developed during their time working together.

Conclusion: Douglas C. Beshore’s contributions to pharmacology through his patents demonstrate his dedication to improving medical treatments for neurological and psychiatric conditions. With a substantial number of patents and collaborations, his work continues to influence the landscape of pharmaceutical innovations, promising further advancements in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…